1.5 - 3 g IV q6-8h
Higher doses may be used for infections due to MDR Acinetobacter spp.
human or animal bites if parenteral therapy is needed
culture-negative endocarditis (ID consult advised)
multi-drug resistant (MDR) Acinetobacter spp. (ID consult advised)
Empiric treatment of biliary tract infections, diverticulitis, or secondary/peritonitis/GI perforation.
Use should be limited to infections that are proven to be susceptible.